Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 6103
  • 6104
  • 6105
  • …
  • ›
  • »

2026-03-17

Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD

2026-03-17

Revival Gold Inc.: Revival Gold Targets Underground Resource Growth With Drilling at Beartrack-Arnett Gold Project in Idaho

2026-03-17

CANEX Metals Inc.: Canex Announces Results of Gold Basin Resources Corporation Annual General Meeting

2026-03-17

Form 8.3 - Life Science REIT Plc

2026-03-17

Abeona Therapeutics GAAP EPS of $1.01 misses by $0.17, revenue of $5.82M beats by $0.6M

2026-03-17

Coffee Holding shares rally continues following Q1 revenue surge

2026-03-17

Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson′s Disease at AD/PD 2026 Conference

2026-03-17

Corporación América Airports S.A. Reports Fourth Quarter and Full Year 2025 Results

2026-03-17

Xtract One Chosen by Morgan County Schools for Amplified Security at District′s High School Campuses

2026-03-17

Rekor Systems to Announce 2025 Results

2026-03-17

Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Argentina and Mexico

2026-03-17

Knight Therapeutics Announces Approval of Additional Indication for MINJUVI® (tafasitamab) in Brazil

  • «
  • ‹
  • …
  • 6103
  • 6104
  • 6105
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies